322 related articles for article (PubMed ID: 21514614)
21. [Clinical characteristics and surgery outcomes of unilateral nodular adrenal hyperplasia in primary aldosteronism: study of 145 cases].
Wu JC; Tang ZY; Zhang W; Ling DY; Hou RF; Wang WQ; Li XY; Ning G
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(46):3302-5. PubMed ID: 17313818
[TBL] [Abstract][Full Text] [Related]
22. Cardiac Remodeling in Patients With Primary and Secondary Aldosteronism: A Tissue Doppler Study.
Cesari M; Letizia C; Angeli P; Sciomer S; Rosi S; Rossi GP
Circ Cardiovasc Imaging; 2016 Jun; 9(6):. PubMed ID: 27307552
[TBL] [Abstract][Full Text] [Related]
23. Predictive factors of left ventricular mass changes after treatment of primary aldosteronism.
Catena C; Colussi GL; Marzano L; Sechi LA
Horm Metab Res; 2012 Mar; 44(3):188-93. PubMed ID: 22351477
[TBL] [Abstract][Full Text] [Related]
24. Dietary Salt Intake Is a Determinant of Cardiac Changes After Treatment of Primary Aldosteronism: A Prospective Study.
Catena C; Colussi G; Novello M; Verheyen ND; Bertin N; Pilz S; Tomaschitz A; Sechi LA
Hypertension; 2016 Jul; 68(1):204-12. PubMed ID: 27245179
[TBL] [Abstract][Full Text] [Related]
25. The association of serum potassium level with left ventricular mass in patients with primary aldosteronism.
Lin YH; Wang SM; Wu VC; Lee JK; Kuo CC; Yen RF; Liu KL; Huang KH; Chueh SC; Wang WJ; Lin LY; Chien KL; Ho YL; Chen MF; Wu KD;
Eur J Clin Invest; 2011 Jul; 41(7):743-50. PubMed ID: 21250985
[TBL] [Abstract][Full Text] [Related]
26. Primary hyperaldosteronism in the era of laparoscopic adrenalectomy.
Rossi H; Kim A; Prinz RA
Am Surg; 2002 Mar; 68(3):253-6; discussion 256-7. PubMed ID: 11893103
[TBL] [Abstract][Full Text] [Related]
27. Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma.
Rossi GP; Sacchetto A; Pavan E; Palatini P; Graniero GR; Canali C; Pessina AC
Circulation; 1997 Mar; 95(6):1471-8. PubMed ID: 9118515
[TBL] [Abstract][Full Text] [Related]
28. Outcomes of laparoscopic adrenalectomy for hyperaldosteronism.
Pang TC; Bambach C; Monaghan JC; Sidhu SB; Bune A; Delbridge LW; Sywak MS
ANZ J Surg; 2007 Sep; 77(9):768-73. PubMed ID: 17685956
[TBL] [Abstract][Full Text] [Related]
29. Long-term treatment with valsartan improved cyclic variation of the myocardial integral backscatter signal and diastolic dysfunction in hypertensive patients: the echocardiographic assessment.
Mizuta Y; Kai H; Mizoguchi M; Osada K; Tahara N; Nakaura H; Kuwahara F; Imaizumi T;
Hypertens Res; 2008 Oct; 31(10):1835-42. PubMed ID: 19015589
[TBL] [Abstract][Full Text] [Related]
30. Incremental value of ultrasonic tissue characterization (backscatter) in the evaluation of left ventricular myocardial structure and mechanics in essential arterial hypertension.
Di Bello V; Giorgi D; Talini E; Dell' Omo G; Palagi C; Romano MF; Pedrinelli R; Mariani M
Circulation; 2003 Jan; 107(1):74-80. PubMed ID: 12515746
[TBL] [Abstract][Full Text] [Related]
31. Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma.
Letavernier E; Peyrard S; Amar L; Zinzindohoué F; Fiquet B; Plouin PF
J Hypertens; 2008 Sep; 26(9):1816-23. PubMed ID: 18698217
[TBL] [Abstract][Full Text] [Related]
32. Left ventricle myocardial mechanics and textural properties in patients with Williams syndrome.
Verrengia M; Pacileo G; Limongelli G; Di Salvo G; Rea A; Iacomino M; Di Simone A; Russo MG; Calabrò R
J Cardiovasc Med (Hagerstown); 2007 May; 8(5):330-6. PubMed ID: 17443098
[TBL] [Abstract][Full Text] [Related]
33. Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I.
Stowasser M; Sharman J; Leano R; Gordon RD; Ward G; Cowley D; Marwick TH
J Clin Endocrinol Metab; 2005 Sep; 90(9):5070-6. PubMed ID: 15941863
[TBL] [Abstract][Full Text] [Related]
34. Left ventricular structural characteristics in unilateral renovascular hypertension and primary aldosteronism.
Suzuki T; Abe H; Nagata S; Saitoh F; Iwata S; Ashizawa A; Kuramochi M; Omae T
Am J Cardiol; 1988 Dec; 62(17):1224-7. PubMed ID: 2973734
[TBL] [Abstract][Full Text] [Related]
35. Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism.
Brilla CG; Matsubara LS; Weber KT
J Mol Cell Cardiol; 1993 May; 25(5):563-75. PubMed ID: 8377216
[TBL] [Abstract][Full Text] [Related]
36. Outcomes of adrenalectomy in patients with primary hyperaldosteronism--a single centre experience.
Hartmann I; Grepl M; Vidlar A; Smakal O; Vaclavik J; Frysak Z; Dolezel M; Student V
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Dec; 158(4):583-90. PubMed ID: 25471827
[TBL] [Abstract][Full Text] [Related]
37. [Long-term blood pressure outcome after unilateral adrenalectomy for primary hyperaldosteronism].
Saint F; Prader R; Cordonnier C; Choukroun G; Elesper N; Desailloud R
Prog Urol; 2017 May; 27(6):389-394. PubMed ID: 28259701
[TBL] [Abstract][Full Text] [Related]
38. Potential reduction of interstitial myocardial fibrosis with renal denervation.
Doltra A; Messroghli D; Stawowy P; Hassel JH; Gebker R; Leppänen O; Gräfe M; Schneeweis C; Schnackenburg B; Fleck E; Kelle S
J Am Heart Assoc; 2014 Dec; 3(6):e001353. PubMed ID: 25516438
[TBL] [Abstract][Full Text] [Related]
39. Regression of left ventricular hypertrophy in patients with primary aldosteronism/low-renin hypertension on low-dose spironolactone.
Ori Y; Chagnac A; Korzets A; Zingerman B; Herman-Edelstein M; Bergman M; Gafter U; Salman H
Nephrol Dial Transplant; 2013 Jul; 28(7):1787-93. PubMed ID: 23378418
[TBL] [Abstract][Full Text] [Related]
40. Left ventricular hypertrophy is more prominent in patients with primary aldosteronism than in patients with other types of secondary hypertension.
Tanabe A; Naruse M; Naruse K; Hase M; Yoshimoto T; Tanaka M; Seki T; Demura R; Demura H
Hypertens Res; 1997 Jun; 20(2):85-90. PubMed ID: 9220271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
